Purchases and Sales Made in Q4 2023 in Arcutis Biotherapeutics, Inc. (ARQT)
This table provides information about the institutional ownership of Arcutis Biotherapeutics, Inc. (ARQT) during Q4 2023. The information is specifically focused on institutions that hold shares of Arcutis Biotherapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2024
Q4 2023
|
Suvretta Capital Management, LLC
New York, NY |
BUY
|
- |
7.34M+ 646.38% |
$13.5M - $35.4M
|
8.47M
$120M
|
|
|
Feb 13, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
BUY
|
- |
5.86M+ 2639.63% |
$10.8M - $28.3M
|
6.08M
$85.8M
|
|
|
Feb 01, 2024
Q4 2023
|
Jennison Associates LLC
|
BUY
|
- |
4.63M+ 104.55% |
$8.53M - $22.3M
|
9.07M
$128M
|
|
|
Feb 09, 2024
Q4 2023
|
Franklin Resources Inc
San Mateo, CA |
BUY
|
- |
3.36M+ 260.24% |
$6.19M - $16.2M
|
4.66M
$65.7M
|
|
|
Feb 14, 2024
Q4 2023
|
Polar Capital Holdings PLC
London, X0 |
BUY
|
- |
3.18M+ 101.98% |
$5.85M - $15.3M
|
6.3M
$88.9M
|
|
|
Feb 13, 2024
Q4 2023
|
Vestal Point Capital, LP
New York, NY |
BUY
|
- |
2.7MNew |
$4.97M - $13M
|
2.7M
$38.1M
|
|
|
Feb 12, 2024
Q4 2023
|
Stem Point Capital LP
New York, NY |
BUY
|
- |
2.59MNew |
$4.77M - $12.5M
|
2.59M
$36.6M
|
|
|
Feb 14, 2024
Q4 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
2.56MNew |
$4.71M - $12.3M
|
2.56M
$36.1M
|
|
|
Aug 16, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
BUY
|
- |
2.11M+ 53.12% |
$3.88M - $10.2M
|
6.08M
$85.8M
|
|
|
Feb 14, 2024
Q4 2023
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
2.02M+ 70.05% |
$3.71M - $9.72M
|
4.9M
$69.1M
|
|
|
Feb 14, 2024
Q4 2023
|
Opaleye Management Inc.
Boston, MA |
BUY
|
- |
1.96MNew |
$3.61M - $9.45M
|
1.96M
$27.7M
|
|
|
Feb 13, 2024
Q4 2023
|
Black Rock Inc.
New York, NY |
BUY
|
- |
1.9M+ 47.16% |
$3.49M - $9.14M
|
5.92M
$83.5M
|
|
|
Feb 13, 2024
Q4 2023
|
Rubric Capital Management LP
New York, NY |
BUY
|
- |
1.61M+ 31.98% |
$2.96M - $7.76M
|
6.64M
$93.8M
|
|
|
Feb 14, 2024
Q4 2023
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
BUY
|
- |
1.36M+ 4492.62% |
$2.51M - $6.57M
|
1.39M
$19.7M
|
|
|
Feb 14, 2024
Q4 2023
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
BUY
|
- |
1.2M+ 145.73% |
$2.22M - $5.8M
|
2.03M
$28.6M
|
|
|
Feb 14, 2024
Q4 2023
|
Ameriprise Financial Inc
Minneapolis, MN |
BUY
|
- |
1.08MNew |
$1.99M - $5.2M
|
1.08M
$15.2M
|
|
|
Feb 14, 2024
Q4 2023
|
Two Sigma Investments, LP
New York, NY |
BUY
|
- |
979KNew |
$1.8M - $4.72M
|
979K
$13.8M
|
|
|
Feb 13, 2024
Q4 2023
|
American Century Companies Inc
Kansas City, MO |
BUY
|
- |
912KNew |
$1.68M - $4.39M
|
912K
$12.9M
|
|
|
Feb 13, 2024
Q4 2023
|
Pivotal Bio Venture Partners Investment Advisor LLC
San Francisco, CA |
BUY
|
- |
805K+ 72.8% |
$1.48M - $3.88M
|
1.91M
$27M
|
|
|
Feb 12, 2024
Q4 2023
|
Tejara Capital LTD
London, X0 |
BUY
|
- |
803K+ 259.73% |
$1.48M - $3.87M
|
1.11M
$15.7M
|
|
|
Feb 13, 2024
Q4 2023
|
Qube Research & Technologies LTD
London, X0 |
BUY
|
- |
726KNew |
$1.34M - $3.5M
|
726K
$10.2M
|
|
|
Feb 13, 2024
Q4 2023
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
706K+ 67.98% |
$1.3M - $3.4M
|
1.74M
$24.6M
|
|
|
Jan 31, 2024
Q4 2023
|
Federated Hermes, Inc.
Pittsburgh, PA |
BUY
|
- |
461K+ 769.12% |
$849K - $2.22M
|
521K
$7.36M
|
|
|
Feb 13, 2024
Q4 2023
|
Prudential Financial Inc
Newark, NJ |
BUY
|
- |
455K+ 125.1% |
$837K - $2.19M
|
818K
$11.5M
|
|
|
Feb 13, 2024
Q4 2023
|
Goldman Sachs Group Inc
New York, NY |
BUY
|
- |
400K+ 120.11% |
$736K - $1.93M
|
733K
$10.3M
|
|
|
Feb 13, 2024
Q4 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
395KNew |
$727K - $1.9M
|
395K
$5.57M
|
|
|
Feb 13, 2024
Q4 2023
|
Acadian Asset Management LLC
Boston, MA |
BUY
|
- |
354KNew |
$652K - $1.71M
|
354K
$5M
|
|
|
Feb 14, 2024
Q4 2023
|
Walleye Capital LLC
Plymouth, MN |
BUY
|
- |
324KNew |
$595K - $1.56M
|
324K
$4.57M
|
|
|
Feb 14, 2024
Q4 2023
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
BUY
|
- |
320KNew |
$589K - $1.54M
|
320K
$4.52M
|
|
|
Feb 14, 2024
Q4 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
- |
291K+ 758.84% |
$535K - $1.4M
|
329K
$4.64M
|
|
|
Feb 14, 2024
Q4 2023
|
Aqr Capital Management LLC
Greenwich, CT |
BUY
|
- |
289KNew |
$532K - $1.39M
|
289K
$4.08M
|
|
|
Feb 14, 2024
Q4 2023
|
Adar1 Capital Management, LLC
Austin, TX |
BUY
|
- |
275KNew |
$506K - $1.33M
|
275K
$3.88M
|
|
|
Feb 13, 2024
Q4 2023
|
Northern Trust Corp
Chicago, IL |
BUY
|
- |
247K+ 51.14% |
$455K - $1.19M
|
731K
$10.3M
|
|
|
Feb 13, 2024
Q4 2023
|
Myda Advisors LLC
Inwood, NY |
BUY
|
- |
220KNew |
$405K - $1.06M
|
220K
$3.1M
|
|
|
Feb 06, 2024
Q4 2023
|
Los Angeles Capital Management LLC
|
BUY
|
- |
194KNew |
$358K - $937K
|
194K
$2.74M
|
|
|
Feb 06, 2024
Q4 2023
|
Charles Schwab Investment Management Inc
San Francisco, CA |
BUY
|
- |
188K+ 48.85% |
$345K - $904K
|
571K
$8.06M
|
|
|
Feb 14, 2024
Q4 2023
|
Pennant Investors, LP
Summit, NJ |
BUY
|
- |
171KNew |
$314K - $824K
|
171K
$2.41M
|
|
|
Feb 14, 2024
Q4 2023
|
J. Goldman & CO LP
New York, NY |
BUY
|
- |
168KNew |
$309K - $808K
|
168K
$2.37M
|
|
|
Feb 14, 2024
Q4 2023
|
Squarepoint Ops LLC
New York, NY |
BUY
|
- |
149KNew |
$275K - $720K
|
149K
$2.11M
|
|
|
Jan 31, 2024
Q4 2023
|
Abrdn PLC
|
BUY
|
- |
149KNew |
$274K - $718K
|
149K
$2.1M
|
|
|
Jan 24, 2024
Q4 2023
|
Deka Bank Deutsche Girozentrale
|
BUY
|
- |
140KNew |
$258K - $675K
|
140K
$1.98M
|
|
|
Feb 13, 2024
Q4 2023
|
Xtx Topco LTD
London, X0 |
BUY
|
- |
123K+ 522.6% |
$226K - $591K
|
146K
$2.06M
|
|
|
Feb 14, 2024
Q4 2023
|
Cubist Systematic Strategies, LLC
Stamford, CT |
BUY
|
- |
107KNew |
$197K - $517K
|
107K
$1.51M
|
|
|
Feb 14, 2024
Q4 2023
|
Lpl Financial LLC
Fort Mill, SC |
BUY
|
- |
106K+ 127.08% |
$195K - $512K
|
190K
$2.68M
|
|
|
Feb 14, 2024
Q4 2023
|
Ghisallo Capital Management LLC
Greenwich, CT |
BUY
|
- |
100KNew |
$184K - $482K
|
100K
$1.41M
|
|
|
Feb 14, 2024
Q4 2023
|
Weiss Multi Strategy Advisers LLC
New York, NY |
BUY
|
- |
96K+ 129.84% |
$177K - $463K
|
170K
$2.4M
|
|
|
Feb 09, 2024
Q4 2023
|
Norges Bank
Oslo, Q8 |
BUY
|
- |
81KNew |
$149K - $390K
|
81K
$1.14M
|
|
|
Feb 14, 2024
Q4 2023
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
BUY
|
- |
80K+ 0.92% |
$147K - $386K
|
8.76M
$124M
|
|
|
Feb 16, 2024
Q4 2023
|
Gsa Capital Partners LLP
London, X0 |
BUY
|
- |
74.9KNew |
$138K - $361K
|
74.9K
$1.06M
|
|
|
Feb 14, 2024
Q4 2023
|
Graham Capital Management, L.P.
Rowayton, CT |
BUY
|
- |
62.4KNew |
$115K - $301K
|
62.4K
$881K
|